Abstract:Background: Analgesic tolerance due to long-term use of morphine remains a challenge for pain management. Morphine acts on mu-opioid receptors and downstream of the phosphatidylinositol 3-kinase signaling pathway to activate the mammalian target of rapamycin (mTOR) pathway. Rheb is an important regulator of growth and cell-cycle progression in the central nervous system owing to its critical role in the activation of mTOR. The hypothesis was that signaling via the GTP-binding protein Rheb in the dorsal horn of the spinal cord is involved in morphine-induced tolerance. Methods: Male and female wild-type C57BL/6J mice or transgenic mice (6 to 8 weeks old) were injected intrathecally with saline or morphine twice daily at 12-h intervals for 5 consecutive days to establish a tolerance model. Analgesia was assessed 60 min later using the tail-flick assay. After 5 days, the spine was harvested for Western blot or immunofluorescence analysis. Results: Chronic morphine administration resulted in the upregulation of spinal Rheb by 4.27 +/- 0.195-fold (P = 0.0036, n = 6), in turn activating mTOR by targeting rapamycin complex 1 (mTORC1). Genetic overexpression of Rheb impaired morphine analgesia, resulting in a tail-flick latency of 4.65 +/- 1.10 s (P < 0.0001, n = 7) in Rheb knock-in mice compared to 10 s in control mice (10 +/- 0 s). Additionally, Rheb overexpression in spinal excitatory neurons led to mTORC1 signaling overactivation. Genetic knockout of Rheb or inhibition of mTORC1 signaling by rapamycin potentiated morphine-induced tolerance (maximum possible effect, 52.60 +/- 9.56% in the morphine + rapamycin group vs. 16.60 +/- 8.54% in the morphine group; P < 0.0001). Moreover, activation of endogenous adenosine 5 '-monophosphate-activated protein kinase inhibited Rheb upregulation and retarded the development of morphine-dependent tolerance (maximum possible effect, 39.51 +/- 7.40% in morphine + metformin group vs. 15.58 +/- 5.79% in morphine group; P < 0.0001). Conclusions: This study suggests spinal Rheb as a key molecular factor for regulating mammalian target of rapamycin signaling.

Expression of Metabotropic Glutamate Receptor 5 in Spinal Cord of Morphine Tolerant Rats

Role of spinal metabotropic glutamate receptor subtype 5 in the development of tolerance to morphine-induced antinociception in rat.

Role of Expression of Protein Kinase C in Spinal Dorsal Horn in Metabotropic Glutamate Receptor 5's Participation in Development of Morphine Tolerance in Rats

EFFECTS OF MPEP ON THE EXPRESSION OF IP3R-Ⅰ IN THE SPINAL CORD OF MORPHINE TOLERANT RATS

Effect of Metabotropic Glutamate 5 Receptor Antagonists on Morphine Efficacy and Tolerance in Rats with Neuropathic Pain.

Inhibition of MPEP on the Development of Morphine Antinociceptive Tolerance and the Biosynthesis of Neuronal Nitric Oxide Synthase in Rat Spinal Cord.

THE ROLE OF G PROTEIN EXPRESSION IN THE PARTICIPATION OF METABOTROPIC GLUTAMATE RECEPTOR 5 IN MORPHINE TOLERANCE

Inhibitory Effect of Spinal Mglu(5) Receptor Antisense Oligonucleotide on the Up-Regulated Expression of Spinal G Protein Associated with Chronic Morphine Treatment.

Inhibitory effects of Group I metabotropic glutamate receptors antagonists on the expression of NMDA receptor NR1 subunit in morphine tolerant rats.

Antisense oligonucleotide knockdown of mGlu₅ receptor attenuates the antinociceptive tolerance and up-regulated expression of spinal protein kinase C associated with chronic morphine treatment.

Metabotropic Glutamate Receptor 5 Signalling Induced NMDA Receptor Subunits Alterations During the Development of Morphine-Induced Antinociceptive Tolerance in Mouse Cortex

Expression of NMDA Receptor Subunit 2A in the Spinal Cord of Morphine Tolerant Rats

Inhibitory Effects of Mas-Related Gene C Receptor on Chronic Morphine-Induced Spinal Glial Activation in Rats

Effects of group Ⅰ metabotropic glutamate receptor antagonist on thermal pain threshold in morphine tolerant rats

Increased Glutamate Synaptic Transmission in the Nucleus Raphe Magnus Neurons from Morphine-Tolerant Rats

Inhibition of Morphine Tolerance by MrgC Receptor Via Modulation of Interleukin-1Β and Matrix Metalloproteinase 9 in Dorsal Root Ganglia in Rats.

Role of P2X7 Receptor-Mediated IL-18/IL-18R Signaling in Morphine Tolerance: Multiple Glial-Neuronal Dialogues in the Rat Spinal Cord.

Activation of P38 Mitogen-Activated Protein Kinase in Spinal Microglia Mediates Morphine Antinociceptive Tolerance

Blockade of mGluR5 in nucleus accumbens modulates calcium sensor proteins, facilitates extinction, and attenuates reinstated morphine place preference in rats

Small G-Protein Rheb Gates Mammalian Target of Rapamycin Signaling to Regulate Morphine Tolerance in Mice.

Small G-Protein Rheb Gates Mtor Signaling to Regulate Morphine Tolerance in Mice